Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 17.15 is 54% above its 5-year average of 11.14, around the middle of its 5-year range (0.12–35.74).
As of the fiscal period ended Tuesday, June 30, 2026. 2.53% above its 12-month average of 16.73.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 17.15.
CURRENT RATIO
17.15
CURRENT RATIO AVG TTM
16.73
CURRENT RATIO AVG 3Y
10.88
CURRENT RATIO AVG 5Y
11.14
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.53%
CURRENT VS 3Y AVG
+57.61%
CURRENT VS 5Y AVG
+53.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+357.31%
vs the sector median at left
Cardio Diagnostics Holdings, Inc.
Market Cap
$5.92M
Current Ratio
17.15
TTM Avg
16.73
3Y Avg
10.88
5Y Avg
11.14
Market Cap
$5.89M
Current Ratio
2.99
TTM Avg
2.79
3Y Avg
3.17
5Y Avg
3.10
Market Cap
$5.82M
Current Ratio
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$5.73M
Current Ratio
119.39
TTM Avg
100.04
3Y Avg
53.39
5Y Avg
40.10
Market Cap
$5.70M
Current Ratio
11.70
TTM Avg
17.23
3Y Avg
23.62
5Y Avg
22.05
Market Cap
$5.63M
Current Ratio
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | $5.92M | 17.15 | 16.73 | 10.88 | 11.14 |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.89M | 2.99 | 2.79 | 3.17 | 3.10 |
| Lucyd, Inc (LUCY)vs › | $5.83M | 12.06 | 10.77 | 9.40 | 6.47 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.82M | 2.35 | 1.31 | 0.84 | 0.78 |
| Scienture Holdings, Inc. (SCNX)vs › | $6.11M | 3.04 | 1.85 | 1.23 | 3.43 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.73M | 119.39 | 100.04 | 53.39 | 40.10 |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | 11.70 | 17.23 | 23.62 | 22.05 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 3.88 | 2.19 | 2.86 | 5.66 |
| Femasys Inc. (FEMY)vs › | $6.28M | 2.14 | 2.73 | 5.58 | 6.46 |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | 10.60 | 4.75 | 13.42 | 23.90 |
Current Ratio
17.15
Quick Ratio
17.15
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 17.15 |
| 2026-03-31 | 15.76 |
| 2025-12-31 | 9.79 |
| 2025-09-30 | 17.39 |
| 2025-06-30 | 23.55 |
| 2025-03-31 | 19.49 |
| 2024-12-31 | 13.92 |
| 2024-09-30 | 8.51 |
| 2024-06-30 | 5.69 |
| 2024-03-31 | 3.78 |
| 2023-12-31 | 3.29 |
| 2023-09-30 | 1.53 |
| 2023-06-30 | 1.63 |
| 2023-03-31 | 1.59 |
| 2022-12-31 | 3.02 |
| 2022-09-30 | 35.74 |
| 2022-06-30 | 18.42 |
| 2022-03-31 | 9.48 |
| 2021-12-31 | 23.71 |
| 2021-09-30 | 0.12 |
| 2021-06-30 | 0.43 |
| 2021-03-31 | 0.00 |
